Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-VEGF Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04870177
What this trial is testing

Study of AK112 in the Treatment of Advanced Gynecological Tumors

Who this might be right for
Gynecologic CancerCancer MetastaticOvarian Neoplasms+2 more
Akeso 53
Large-scale testing (Phase 3)Study completedNCT00599222
What this trial is testing

The Ranibizumab Plus Transpupillary Thermotherapy for Neovascular Age-Related Macular Degeneration (AMD) Study

Who this might be right for
Neovascular Age-related Macular Degeneration
Anders Kvanta 100
Not applicableWithdrawnNCT01218230
What this trial is testing

Intravitreal Pegaptanib in Treatment of Choroidal Neovascularisation Secondary to Pathologic Myopia

Who this might be right for
Myopic Choroidal Neovascular Membrane
L.V. Prasad Eye Institute
Not applicableEnded earlyNCT02650050
What this trial is testing

Micropulsed Laser in Association With Anti-VEGF for the Treatment of Macular Edema in Diabetic Patients (LAMED).

Who this might be right for
Macular EdemaMellitus Diabetes
Fondation Ophtalmologique Adolphe de Rothschild 5
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07244978
What this trial is testing

Neoadjuvant Ivonescimab（AK112） Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaNeoadjuvant Therapy
Second Affiliated Hospital, Zhejiang University, School of Medicine 49
Early research (Phase 1)UnknownNCT03503604
What this trial is testing

Anti-VEGF Monoclonal Antibody hPV19 in Patients With Solid Tumors

Who this might be right for
Solid Tumors
SuZhou Stainwei Biotech Inc. 18
Testing effectiveness (Phase 2)Ended earlyNCT05571267
What this trial is testing

Safety Study of Zimura in Combination With Anti-VEGF Therapy in Patients With Neovascular AMD

Who this might be right for
Neovascular Age-Related Macular Degeneration
IVERIC bio, Inc. 1
Early research (Phase 1)Study completedNCT01392209
What this trial is testing

Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma

Who this might be right for
Brain CancerMALIGNANT GLIOMAGlioblastoma+5 more
Memorial Sloan Kettering Cancer Center 15
Large-scale testing (Phase 3)Active Not RecruitingNCT04704921
What this trial is testing

Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD

Who this might be right for
AMDnAMDWet Age-related Macular Degeneration+6 more
AbbVie 671
Not applicableStudy completedNCT01448538
What this trial is testing

Non-Persistence/Non-Adherence (NP/NA) in Wet Age-related Macular Degeneration (wAMD) Patients in Germany

Who this might be right for
Wet Macular Degeneration
Bayer 480
Testing effectiveness (Phase 2)Looking for participantsNCT07335497
What this trial is testing

CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced / Metastatic Solid Tumors
Crescent Biopharma, Inc. 290
Not applicableNot Yet RecruitingNCT05512325
What this trial is testing

Study on Gene Evolution in Glioma Under Stress Therapy

Who this might be right for
Genetic Change
Henan Provincial People's Hospital 100
Not applicableStudy completedNCT02541084
What this trial is testing

Caregiver Burden of Wet Age-related Macular Degeneration (wAMD) in Japan

Who this might be right for
Wet Macular Degeneration
Bayer 72
Testing effectiveness (Phase 2)Study completedNCT00354978
What this trial is testing

Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients

Who this might be right for
Colorectal Cancer
M.D. Anderson Cancer Center 49
Post-approval studies (Phase 4)Study completedNCT01500915
What this trial is testing

FUSION Regimen: Combined Pro re Nata and Fixed Regimen Ranibizumab in Exudative Age-related Macular Degeneration

Who this might be right for
Exudative Age-related Macular Degeneration
Institut de la Macula y la Retina 17
Early research (Phase 1)Study completedNCT00491855
What this trial is testing

Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis

Who this might be right for
Peritoneal Cancer
M.D. Anderson Cancer Center 3
Not applicableStudy completedNCT05472376
What this trial is testing

Real-Life Study in Diabetic Macular Edema

Who this might be right for
Diabetic Macular Edema
Kocaeli University 854
Testing effectiveness (Phase 2)Study completedNCT01664182
What this trial is testing

Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer

Who this might be right for
Advanced Renal Cell CarcinomaAdvanced Sarcomatoid Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v7+1 more
National Cancer Institute (NCI) 41
Not applicableStudy completedNCT05146687
What this trial is testing

Real-world Evaluation of Prevalence of Ocular Adverse Events in Patients With Neovascular (Wet) Age-related Macular Degeneration (AMD) Who Received Anti-vascular Endothelial Growth Factor (VEGF) Agents (Komodo Health)

Who this might be right for
Age-related Macular Degeneration (AMD)
Novartis Pharmaceuticals 369,600
Not applicableStudy completedNCT03161912
What this trial is testing

Evaluate the Effectiveness of Intravitreal Aflibercept in Patients With Diabetic Macular Edema and/or Macular Edema Secondary to Retinal Vein Occlusion, Which Either Have or Have Not Been Pretreated for Their Disease

Who this might be right for
Macular Edema
Bayer 2,481
Next Page